Diabetes 53:2404-2411, 2004
© 2004 by the American Diabetes Association, Inc.
Studies of Rat and Human Retinas Predict a Role for the Polyol Pathway in Human Diabetic Retinopathy
Zeina Dagher,
Yong Seek Park,
Veronica Asnaghi,
Todd Hoehn,
Chiara Gerhardinger, and
Mara Lorenzi
Department of Ophthalmology, Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts
The polyol (sorbitol) pathway of glucose metabolism is activated in many cell types when intracellular glucose concentrations are high, and it can generate cellular stress through several mechanisms. The role of the polyol pathway in the pathogenesis of diabetic retinopathy has remained uncertain, in part because it has been examined preferentially in galactose-induced retinopathy and in part because inhibition studies may not have achieved full blockade of the pathway. Having observed that the streptozotocin-induced diabetic rat accurately models many cellular processes characteristic of human diabetic retinopathy, we tested in the diabetic rat if documented inhibition of the polyol pathway prevents a sequence of retinal vascular abnormalities also present in human diabetes. An inhibitor of aldose reductase, the rate-limiting enzyme in the pathway, prevented the early activation of complement in the wall of retinal vessels and the decreased levels of complement inhibitors in diabetic rats, as well as the later apoptosis of vascular pericytes and endothelial cells and the development of acellular capillaries. Both rat and human retinal endothelial cells showed aldose reductase immunoreactivity, and human retinas exposed to high glucose in organ culture increased the production of sorbitol by a degree similar to that observed in the rat. Excess aldose reductase activity can be a mechanism for human diabetic retinopathy.
Address correspondence and reprint requests to Mara Lorenzi, MD, Harvard Medical School, Schepens Eye Research Institute, 20 Staniford St., Boston, MA 02114. E-mail: lorenzi{at}vision.eri.harvard.edu

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Kobayashi and D. G. Puro
Loss of Insulin-Mediated Vasoprotection: Early Effect of Diabetes on Pericyte-Containing Microvessels of the Retina
Invest. Ophthalmol. Vis. Sci.,
May 1, 2007;
48(5):
2350 - 2355.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Sun, P. J. Oates, J. B. Coutcher, C. Gerhardinger, and M. Lorenzi
A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
Diabetes,
October 1, 2006;
55(10):
2757 - 2762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. H. Diederen, C. A. Starnes, B. A. Berkowitz, and B. S. Winkler
Reexamining the hyperglycemic pseudohypoxia hypothesis of diabetic oculopathy.
Invest. Ophthalmol. Vis. Sci.,
June 1, 2006;
47(6):
2726 - 2731.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Ola, D. A. Berkich, Y. Xu, M. T. King, T. W. Gardner, I. Simpson, and K. F. LaNoue
Analysis of glucose metabolism in diabetic rat retinas
Am J Physiol Endocrinol Metab,
June 1, 2006;
290(6):
E1057 - E1067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. Miller, D. G. Smith, M. Bhat, and R. H. Nagaraj
Glyoxalase I Is Critical for Human Retinal Capillary Pericyte Survival under Hyperglycemic Conditions
J. Biol. Chem.,
April 28, 2006;
281(17):
11864 - 11871.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Berrone, E. Beltramo, C. Solimine, A. U. Ape, and M. Porta
Regulation of Intracellular Glucose and Polyol Pathway by Thiamine and Benfotiamine in Vascular Cells Cultured in High Glucose
J. Biol. Chem.,
April 7, 2006;
281(14):
9307 - 9313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.T. Graves, R. Liu, M. Alikhani, H. Al-Mashat, and P.C. Trackman
Diabetes-enhanced Inflammation and Apoptosis--Impact on Periodontal Pathology
J. Dent. Res.,
January 1, 2006;
85(1):
15 - 21.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Sun, C. Gerhardinger, Z. Dagher, T. Hoehn, and M. Lorenzi
Aspirin at Low-Intermediate Concentrations Protects Retinal Vessels in Experimental Diabetic Retinopathy Through Non-Platelet-Mediated Effects
Diabetes,
December 1, 2005;
54(12):
3418 - 3426.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Cacicedo, S. Benjachareowong, E. Chou, N. B. Ruderman, and Y. Ido
Palmitate-Induced Apoptosis in Cultured Bovine Retinal Pericytes: Roles of NAD(P)H Oxidase, Oxidant Stress, and Ceramide
Diabetes,
June 1, 2005;
54(6):
1838 - 1845.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Gerhardinger, M. B. Costa, M. C. Coulombe, I. Toth, T. Hoehn, and P. Grosu
Expression of Acute-Phase Response Proteins in Retinal Muller Cells in Diabetes
Invest. Ophthalmol. Vis. Sci.,
January 1, 2005;
46(1):
349 - 357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. G. Obrosova, P. Pacher, C. Szabo, Z. Zsengeller, H. Hirooka, M. J. Stevens, and M. A. Yorek
Aldose Reductase Inhibition Counteracts Oxidative-Nitrosative Stress and Poly(ADP-Ribose) Polymerase Activation in Tissue Sites for Diabetes Complications
Diabetes,
January 1, 2005;
54(1):
234 - 242.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Diabetes Association.
|
|
| |
|